The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer.
Autorzy:
Hagi T; Department of Surgery, Washington University School of Medicine, S. Euclid Avenue, St. Louis, MO, 63110, USA. Vangveravong S; Department of Surgery, Washington University School of Medicine, S. Euclid Avenue, St. Louis, MO, 63110, USA. Takchi R; Department of Surgery, Washington University School of Medicine, S. Euclid Avenue, St. Louis, MO, 63110, USA. Gong Q; Department of Surgery, Washington University School of Medicine, S. Euclid Avenue, St. Louis, MO, 63110, USA. Goedegebuure SP; Department of Surgery, Washington University School of Medicine, S. Euclid Avenue, St. Louis, MO, 63110, USA.; Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, MO, USA. Tiriac H; Division of Surgical Oncology, Department of Surgery, Moores Cancer Center, University of California San Diego, San Diego, CA, USA, San Diego, USA. VanTineBA; Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, MO, USA.; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO, USA. Powell MA; Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, MO, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA. Hawkins WG; Department of Surgery, Washington University School of Medicine, S. Euclid Avenue, St. Louis, MO, 63110, USA. .; Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, MO, USA. . Spitzer D; Department of Surgery, Washington University School of Medicine, S. Euclid Avenue, St. Louis, MO, 63110, USA. .; Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, MO, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 16; Vol. 14 (1), pp. 6373. Date of Electronic Publication: 2024 Mar 16.
Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With Leiomyosarcoma.
Autorzy:
Gao L; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA. Kaushik D; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA. VanTineBA; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.; Division of Pediatric Hematology/Oncology, St. Louis Children's Hospital, St. Louis, MO, USA.; Siteman Cancer Center, St. Louis, MO, USA. Ingham MA; Columbia University Medical Center, New York, NY, USA. Attia S; Mayo Clinic, Jacksonville, FL, USA. Meyer CF; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. Schwartz GK; Columbia University Medical Center, New York, NY, USA. Maliakal P; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA. Baird JD; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA. Ma J; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA. Barrett R; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA. D'Silva D; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA. O'Keefe K; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA. Kong R; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, USA.
A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.
Autorzy:
Bui N; Stanford Cancer Institute, Palo Alto, CA 94304, USA. Dietz H; Vanderbilt University Medical Center, Nashville, TN 37232, USA. Farag S; Institute of Cancer Research, Royal Marsden Hospital, London SW3 6JJ, UK. Hirbe AC; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO 63110, USA. Wagner MJ; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. VanTineBA; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO 63110, USA. Ganjoo K; Stanford Cancer Institute, Palo Alto, CA 94304, USA. Jones RL; Institute of Cancer Research, Royal Marsden Hospital, London SW3 6JJ, UK. Keedy VL; Vanderbilt University Medical Center, Nashville, TN 37232, USA. Davis EJ; Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 May 05; Vol. 15 (9). Date of Electronic Publication: 2023 May 05.
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy.
Autorzy:
Miller D; University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA. Livingston JA; MD Anderson Cancer Center, Houston, Texas, USA. Park Y; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin, USA. Posey K; MD Anderson Cancer Center, Houston, Texas, USA. Godbole S; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA. Skubitz K; University of Minnesota, Minneapolis, Minnesota, USA. Robinson SI; Mayo Clinic, Rochester, Minnesota, USA. Agulnik M; City of Hope, Duarte, California, USA. Davis LE; Oregon Health & Science University, Portland, Oregon, USA. VanTineBA; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA. Hirbe AC; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA. Parkes A; University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2022 Sep; Vol. 11 (18), pp. 3471-3478. Date of Electronic Publication: 2022 Mar 28.
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial.
Autorzy:
VanTineBA; Washington University in St Louis, MO, USA. Krarup-Hansen A; Department of Oncology, University Hospital, Herlev, Denmark. Hess LM; Eli Lilly and Company, Indianapolis, IN, USA. Abdul Razak AR; Toronto Sarcoma Program, Princess Margaret Cancer Centre, Toronto, ON, Canada. Soldatenkova V; Eli Lilly and Company, Indianapolis, IN, USA. Wright J; Eli Lilly and Company, Indianapolis, IN, USA. Park SH; Sungkyunkwan University Samsung Medical Center, Seoul, South Korea.
Pokaż więcej
Źródło:
Rare tumors [Rare Tumors] 2022 May 05; Vol. 14, pp. 20363613221100033. Date of Electronic Publication: 2022 May 05 (Print Publication: 2022).
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Autorzy:
VanTineBA; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.; Division of Pediatric Hematology and Oncology, St. Louis Children's Hospital, St. Louis, MO, USA.; Siteman Cancer Center, St. Louis, MO, USA. Weiss MC; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.; Siteman Cancer Center, St. Louis, MO, USA. Hirbe AC; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.; Division of Pediatric Hematology and Oncology, St. Louis Children's Hospital, St. Louis, MO, USA.; Siteman Cancer Center, St. Louis, MO, USA. Oppelt PJ; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.; Siteman Cancer Center, St. Louis, MO, USA. Abaricia S; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA. Trinkaus K; Department of Biostatistics, Washington University in St. Louis, St. Louis, MO, USA. Luo J; Department of Biostatistics, Washington University in St. Louis, St. Louis, MO, USA. Berry S; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA. Ruff T; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA. Callahan C; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA. Toensikoetter J; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA. Ley J; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA. Siegel MJ; Siteman Cancer Center, St. Louis, MO, USA.; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO, USA. Dehdashti F; Siteman Cancer Center, St. Louis, MO, USA.; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO, USA. Siegel BA; Siteman Cancer Center, St. Louis, MO, USA.; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO, USA. Adkins DR; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.; Siteman Cancer Center, St. Louis, MO, USA.
Pokaż więcej
Źródło:
Rare tumors [Rare Tumors] 2021 Oct 08; Vol. 13, pp. 20363613211052498. Date of Electronic Publication: 2021 Oct 08 (Print Publication: 2021).
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
Autorzy:
Jones RL; Sarcoma Unit, Royal Marsden Hospital/Institute of Cancer Research, London, UK. Herzog TJ; University of Cincinnati Cancer Center, University of Cincinnati, Cincinnati, OH, USA. Patel SR; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. von Mehren M; Fox Chase Cancer Center, Philadelphia, PA, USA. Schuetze SM; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. VanTineBA; Washington University in St. Louis, St. Louis, MO, USA. Coleman RL; US Oncology Research, The Woodlands, TX, USA. Knoblauch R; Janssen Research & Development, LLC, Raritan, NJ, USA. Triantos S; Janssen Research & Development, LLC, Raritan, NJ, USA. Hu P; Janssen Research & Development, LLC, Raritan, NJ, USA. Shalaby W; Medical Group Oncology, Janssen Scientific Affairs, LLC, Horsham, PA, USA. McGowan T; Medical Group Oncology, Janssen Scientific Affairs, LLC, Horsham, PA, USA. Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, and Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. Demetri GD; Sarcoma Center, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Harvard Medical School and Ludwig Center at Harvard, Boston, MA, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Jun; Vol. 10 (11), pp. 3565-3574. Date of Electronic Publication: 2021 May 07.
Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies.
Autorzy:
Rathore R; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO 63110, USA. VanTineBA; Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO 63110, USA.; Division of Pediatric Hematology and Oncology, St. Louis Children's Hospital, St. Louis, MO 63110, USA.; Siteman Cancer Center, St. Louis, MO 63110, USA.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 Mar 12; Vol. 10 (6). Date of Electronic Publication: 2021 Mar 12.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
